If you're getting men's health treatment through a telehealth platform, there's a good chance at least one of your medications is compounded — custom-mixed by a compounding pharmacy rather than manufactured by a large pharmaceutical company. Compounded semaglutide for weight loss. Compounded topical finasteride for hair loss. Compounded tadalafil-oxytocin combinations for ED. Compounded testosterone formulations for TRT.
Compounding has been a cornerstone of the men's health telehealth model, offering brand-name-equivalent formulations at dramatically lower prices. But the regulatory landscape is shifting, and men relying on compounded medications need to understand what's changing and what it means for their treatment.
Compounded semaglutide exists because of a drug shortage. Under FDA regulations, compounding pharmacies can produce copies of FDA-approved drugs when those drugs are on the shortage list. Semaglutide (the active ingredient in Ozempic and Wegovy) was on that list — until it wasn't.
As manufacturing catches up with demand, the FDA's shortage resolution threatens the legal basis for compounded semaglutide. This creates uncertainty for the dozens of telehealth platforms (and hundreds of thousands of patients) who depend on compounded GLP-1 at $200–400/month rather than brand-name Wegovy at $1,000+.
The industry response has been multifaceted: some platforms (like Hims) have pivoted to distributing brand-name Wegovy directly. Others are exploring different GLP-1 formulations that aren't subject to the same shortage dynamics. Still others are challenging the FDA's shortage determination. For the latest on GLP-1 pricing and availability across platforms, GLP-1 Price List maintains current information, and HealthyWeightMeds covers the broader weight loss treatment landscape.
In April 2025, the FDA issued a safety communication regarding compounded topical finasteride, citing 32 adverse event reports. The concern centered on inconsistent dosing in compounded formulations — some patients may have received higher-than-intended systemic exposure because compounding quality varies between pharmacies.
This doesn't mean topical finasteride is unsafe. The concept — delivering finasteride to the scalp with minimal systemic absorption — is pharmacologically sound and supported by clinical data showing similar efficacy to oral finasteride with dramatically lower plasma levels. The issue is quality control in compounding, not the formulation concept itself.
FinasterideFast covers the full regulatory picture for finasteride, and HairWithConfidence discusses alternatives for men concerned about finasteride in any form.
Don't panic. Regulatory changes don't happen overnight, and your current prescriptions remain valid. Ask your platform about their compounding pharmacy. Reputable platforms use 503B outsourcing facilities (which are FDA-registered and subject to regular inspection), not 503A traditional pharmacies (which have less oversight). Have a backup plan. If compounded semaglutide becomes unavailable, know what your alternatives are — brand-name GLP-1, different medications, or different platforms. Stay informed. The regulatory landscape is actively evolving, and platforms that communicate transparently about changes deserve your business more than those that pretend nothing is happening.
Sesame Care and PeterMD both offer FDA-approved medications alongside compounded options, providing built-in flexibility if the regulatory environment shifts.
Compounded medications have made men's health treatment more affordable and accessible for millions of men. The regulatory scrutiny they're facing is real but not catastrophic — it's pushing the industry toward better quality standards rather than eliminating compounding entirely. Stay informed, use reputable platforms, and have contingency plans for your critical medications.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.
Affiliate Disclosure: MenRxFast may earn a commission from qualifying purchases through affiliate links.
© 2026 MenRxFast. All rights reserved.